Abstract
This work aimed to evaluate the effects of the aqueous extract of Vepris afzelii roots on a rat model of hypogonadism. Phytochemical screening and acute toxicity of the extract were performed using different procedures. Hypogonadism was induced orally in adult Wistar rats using cyproterone acetate (30 mg/kg) for ten days. Besides six normal rats (10 ml/kg of distilled water, normal control), 30 hypogonadal rats were subdivided into five groups of six animals each, receiving for 14 days: distilled water (10 ml/kg, hypogonadal control), testosterone (4 mg/kg/3days) and the extract of V. afzelii (100, 200 and 400 mg/kg). Sexual behavior, sperm parameters, testes function and structure were assessed. Compared to the normal controls, significant (p = 0.0000) increases in mount (24 ± 0.94 seconds vs. 1200 ± 00 seconds) and intromission (49.16 ± 10.85 seconds vs. 1200 ± 00 seconds) latencies, and post-ejaculatory interval (381.72 ± 37.55 seconds vs. 1200 ± 00 seconds) were observed in all groups receiving cyproterone acetate on day 0. Total inhibitions of mounts (63.50 ± 8.91 vs. 00 ± 00), intromissions (36.66 ± 3.51 vs. 00 ± 00) (p = 0.0000), ejaculations (2.83 ± 00 vs. 00 ± 00, p = 0.0002) frequencies and mean copulatory interval (627.30 ± 81.80 vs. 00 ± 00, p = 0.0000) were also observed in these groups. Moreover, decreases in daily sperm production (2.65 ± 0.19 vs. 1.17 ± 0.08, p = 0.0498), percentage of sperm mobility (78.64 ± 8.41 vs. 10.12 ± 2.32), serum testosterone level (8.39 ± 0.63 ng/dl vs. 1.68 ± 0.19 ng/dl), diameter of seminiferous tubules (111.97 ± 0.51 µm vs. 94.51 ± 0.57 µm) and height of germinal epithelium (46.58 ± 0.34 µm vs. 33.74 ± 0.66 µm) (p = 0.0000) associated with increases in sperm transit (3.13 ± 0.45 vs. 11.07 ± 1.45, p = 0.0000) were also observed in these groups. Interestingly, compared to hypogonadal control and day 0, the administration of V. afzelii extract induced significant (p = 0.0000) improvements in all these altered parameters with 400 mg/kg being the most active dose. These results, attributed to saponins, flavonoids, polyphenols and triterpenes detected in this plant’s extract confirm its traditional usage and could be useful for the management of patients suffering from hypogonadism.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The datasets analysed during this study are available from the corresponding author upon request.
References
Rey RA, Grinspon RP, Gottlieb S, Pasqualini T, Knoblovits P, Aszpis S, et al. Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach. Am Soc Androl Eur Acad Androl. 2012;1:3–16.
Kumar P, Kumar N, Thakur DS, Thakur DS, Patidar A. Male hypogonadism: symptoms and treatment. J Adv Pharm Technol Res. 2010;1:297–301.
Fieldman AH, Longcope C, Derby CA, Johannes CB, Aroujo AB, Coviello AD, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87:589–98.
Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60:762–9.
Ventimiglia E, Ippolito S, Capogrosso P, Pederzoli F, Cazzaniga W, Boeri L, et al. Primary, secondary and compensated hypogonadism: a novel risk stratification for infertile men. Andrology. 2017;5:505–10.
George M, Yulia T, Svetlana K. Influence of testosterone gel treatment on spermatogenesis in men with hypogonadism. Gynecol Endocrinol. 2014;30:22–24.
Vigen R, O’Donnell CI, Barón AE, Grunwald GK, Maddox TM, Bradley SM. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013;310:1829–36.
Chen L, Wolff DW, Xie Y, Lin M, Tu Y. Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5. BMC Cancer. 2017;17:11.
Jung M, Oh K, Choi EJ, Oh D, Kim YJ, Bae D. In vitro and in vivo androgen regulation of Dendropanax morbiferus leaf extract on late-onset hypogonadism. Cell Mol Biol (Noisy-le-grand). 2018;64:20–27.
Tripathy A, Ara F, Ghosh P, Ghosh D. Effect of lycopene on testicular androgenic and anti-oxidative enzymes in cyproterone acetate-induced male infertile Wistar strain albino rats: an in vitro study. Andrologia. 2020; https://doi.org/10.1111/and.13494
Nde Z, Massoma LD, Wankeu-Nya M, Ngaha MI, Koloko LB, Bend EF. Potential activity of Aframomum daniellii (Zingiberaceae) dry seeds: a case study of its action mechanism on the Wistar rat strain with testicular deficiency. Biomed Pharmacother. 2020;131:110759.
Rockville MD. US food and drug administration (USFDA). Guidance for industry: estimating the maximum safe starting dose in adult healthy volunteer. 2005
Yakubu, MT, Akanji, MA. Effect of Aqueous Extract of Massularia acuminata Stem on Sexual Behavior of Male Wistar Rats. Evidence-Based Complement Altern Med. 2011; https://doi.org/10.1155/2011/738103
Souza AD, Bessa DH, Fernandes CC, Pereira PS, Martin CH, Miranda ML Phytochemical screening of extracts from Spiranthera odoratissima A. St.-Hil. (Rutaceae) leaves and their in vitro antioxidant and anti-Listeria monocytogenes activities. Acta Sci Biol Sci. 2020; https://doi.org/10.4025/actascibiolsci.v42i1.51881
OECD: Organisation for Economic, Cooperative and Development. Guideline for testing of chemicals, test n°423, acute oral toxicity – acute toxic class method. 2001; 1–14
Cariton AE. Experimental surgery of the genital system. In: Gay WI and Heavener JE (eds). Methods of animal experimentation: research surgery and care of the research animal; part B chirurgical approaches to organ systems. Academic Press, Orlando, 1986, pp 191.
Watcho P, Wankeu-Nya M, Nguelefack TB, Tapondjou L, Teponno R, Kamanyi A. Pro-sexual effects of Dracaena arborea (WILD) LINK (Dracaenaceae) in sexually experienced male rats. Pharmacologyonline. 2007;1:400–19.
Ageel AM, Islam MW, Ginawi OT, Al-Yahya, MA. Evaluation of the aphrodisiac activity of Litsea chinensis (Lauraceae) and Orchis malculata (Orchidaceae) extracts in rats. Phyther Res. 1994; https://doi.org/10.1002/ptr.2650080211
Carro-Juárez M, Cervantes E, Cervantes-Méndez M, Rodríguez-Manzo G. Aphrodisiac properties of Montanoa tomentosa aqueous crude extract in male rats. Pharmacol Biochem Behav. 2004;78:129–34.
Chauhan N, Dixit V. Spermatogenic activity of rhizomes of Curculigo orchioides Gaertn in male rats. Int J Appl Res Nat Prod. 2008;1:26–31.
Robb GW, Amann RP, Killian GJ. Daily sperm production and epididymal sperm reserves of pubertal and adult rats. J Reprod Fertil. 1978;54:103–7.
Ernst EA. Method for evaluation of epididymal sperm count and motility in the rat. Scand J Lab Anim Sci. 1989;16:67–71.
Chen C, Gao G, Ho D, Lin C, Chou Y, Chen S. Cyproterone acetate acts as a disruptor of the aryl hydrocarbon receptor. Sci Rep. 2021; https://doi.org/10.1038/s41598-021-84769-7
Zamblé A, Sahpaz S, Brunet C, Bailleul F. Effects of Microdesmis keayana roots on sexual behavior of male rats. Phytomedicine. 2008;15:625–9.
Yakubu MT, Akanji MA, Oladiji AT, Adesokan AA. Androgenic potentials of aqueous extract of Massularia acuminata (G. Don) Bullock ex Hoyl. stem in male Wistar rats. J Ethnopharmacol. 2008;118:508–13.
Gauthaman K, Ganesan AP. The hormonal effects of Tribulus terrestris and its role in the management of male erectile dysfunction-an evaluation using primates, rabbit and rat. Phytomedicine. 2008;15:44–54.
Moundipa PF, Beboy NS, Zelefack F, Ngouela S, Tsamo E, et al. Effects of Basella alba and Hibiscus macranthus extracts on testosterone production of adult rat and bull Leydig cells. Asian J Androl. 2005;7:411–7.
Kim JY, Wood RI. Anabolic-androgenic steroids and appetitive sexual behavior in male rats. Horm Behav. 2014;66:585–90.
Shimon I, Lubina A, Gorfine M, Ilany J. Feedback inhibition of gonadotropins by testosterone in men with hypogonadotropic hypogonadism: comparison to the intact pituitary-testicular axis in primary hypogonadism. J Androl. 2006;27:358–64.
Kotta S, Ansari SH, Ali J. Exploring scientifically proven herbal aphrodisiacs. Pharmacogn Rev. 2013;7:1–10.
Simanainen U, McNamara K, Davey RA, Zajac JD, Handelsman DJ. Severe subfertility in mice with androgen receptor inactivation in sex accessory organs but not in testis. Endocrinology. 2008;149:3330–8.
Grande G, Barrachina F, Soler-Ventura A, Jodar M, Mancini F, Marana R. The Role of Testosterone in Spermatogenesis: Lessons From Proteome Profiling of Human Spermatozoa in Testosterone Deficiency. Front Endocrinol (Lausanne). 2022. https://doi.org/10.3389/fendo.2022.852661
Kumar GG, Kilari EK, Nelli NB. Oral administration of Turnera diffusa willd. ex Schult. extract ameliorates steroidogenesis and spermatogenesis impairment in the testes of rats with type-2 diabetes mellitus. J Ethnopharmacol. 2023; https://doi.org/10.1016/j.jep.2023.116638.5
Wankeu-Nya M, Florea A, Bâlici S, Watcho P, Matei H, Kamanyi A. Dracaena arborea alleviates ultra-structural spermatogenic alterations in streptozotocin-induced diabetic rats. BMC Complement Altern Med. 2013. https://doi.org/10.1186/1472-6882-13-71
Wankeu-Nya M, Florea A, Bâlici Ş, Matei H, Watcho P, Kamanyi A. Cytoarchitectural improvement in Leydig cells of diabetic rats after treatment with aqueous and ethanol extracts of Dracaena arborea (Dracaenaceae). J Tradit Complement Med. 2021;11:1–8.
Acknowledgements
Authors are grateful to the Alexander Von Humbold Foundation for the laboratory material and equipment offered to one of the authors of this work, Pr Alain Bertrand Dongmo. The authors are also grateful to Jesse Forchap (Lead Biotech Production, Specialist at Regeneron Pharmaceuticals Albany, New York, USA) and Dr Wandja Kamgang Vanessa (Department of Zoology and Entomology, Mammal Research Institute, University of Pretoria, Hatfield, South Africa) for polishing the language.
Author information
Authors and Affiliations
Contributions
WNM, DON and NZ developed the project. DON, KIT and HTD collected and analysed the data. WNM, DON, NZ, KBL and TMC did the literature review and defined the intellectual content. WNM and DON wrote the manuscript. WNM, DAB, MLD, MFP and WP did the manuscript review.
Corresponding author
Ethics declarations
Competing interests
The authors of this paper declare no conflict of interest.
Ethical approval
The protocol of this study was validated by the staff of the Department of Animal Organisms Biology and all the experiments were performed by the guidelines of the institutional ethics committee of the University of Douala as mentioned in the ethical clearance number 2906 CEI-UDo/08/2021/M delivered.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wankeu-Nya, M., Djeumeni, O.N., Nde, Z. et al. Aphrodisiac and androgenic effects of the aqueous extract of the roots of Vepris afzelii on cyproterone acetate-induced hypogonadism in rat. Int J Impot Res (2024). https://doi.org/10.1038/s41443-024-00892-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41443-024-00892-9